A5022465470- Hepatitis C virus research
- Liver Disease Diagnosis and Treatment
- Shoulder Injury and Treatment
- Platelet Disorders and Treatments
- Shoulder and Clavicle Injuries
- Blood transfusion and management
- Liver Disease and Transplantation
- Heparin-Induced Thrombocytopenia and Thrombosis
- Systemic Lupus Erythematosus Research
- Cardiac Valve Diseases and Treatments
- Hepatitis B Virus Studies
- HIV/AIDS drug development and treatment
- Cardiac electrophysiology and arrhythmias
- Diverticular Disease and Complications
- Venous Thromboembolism Diagnosis and Management
- Streptococcal Infections and Treatments
- Liver Diseases and Immunity
- Ion channel regulation and function
- Takotsubo Cardiomyopathy and Associated Phenomena
- Orthopaedic implants and arthroplasty
- Trauma, Hemostasis, Coagulopathy, Resuscitation
- Dermatology and Skin Diseases
- Sepsis Diagnosis and Treatment
Hospital General de Granollers
2023-2024
Hospital Universitario de Burgos
2015-2016
Hôpital l'Archet
2005-2007
Thrombocytopenia (platelet count < 150 × 109/L) is common in intensive care unit (ICU) patients and likely associated with worse outcomes. In this study we present international contemporary data on thrombocytopenia ICU patients. We conducted a prospective cohort adult 52 ICUs across 10 countries. assessed frequencies of thrombocytopenia, use platelet transfusions clinical outcomes including mortality. evaluated pre-selected potential risk factors for the development during stay associations...
Summary Patients with HCV genotype 3 (GT3) infection and cirrhosis are currently the most difficult to cure. We report our experience sofosbuvir+daclatasvir (SOF+DCV) or sofosbuvir/ledipasvir (SOF/LDV), without ribavirin (RBV) in clinical practice this population. This was a multicenter observational study including cirrhotic patients infected by GT3, treated sofosbuvir plus an NS5A inhibitor (May 2014‐October 2015). In total, 208 were included: 98 (47%) treatment‐experienced, 42 (20%)...
Platelet transfusions are frequently used in the intensive care unit (ICU), but current practices including product types, volumes, doses and effects unknown.
There is limited information about prevalence of hepatitis B (HBV) and C virus (HCV) infection in inflammatory bowel disease (IBD). This knowledge relevant because the viruses may be reactivated under immunosuppressive therapy. The aim our study to assess HBV HCV IBD patients a population-based area 4 different hospitals Castilla y Leon evaluate associated risk factors. A descriptive, observational, retrospective multicenter including León was conducted analyse status data compare that some...